Insulet (Nasdaq:PODD) shares ticked up before hours today on second-quarter results that came in ahead of the consensus ...

Senseonics (NYSE:SENS) shares remained relatively unmoved today on second-quarter results that beat the consensus sales ...

(Nasdaq:TNDM) shares fell after hours today on second-quarter results that topped the consensus sales forecast.

The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said ...